Cargando…

Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification

BACKGROUND: Reverse phase protein arrays (RPPA) emerged as a useful experimental platform to analyze biological samples in a high-throughput format. Different signal detection methods have been described to generate a quantitative readout on RPPA including the use of fluorescently labeled antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Brase, Jan C, Mannsperger, Heiko, Fröhlich, Holger, Gade, Stephan, Schmidt, Christian, Wiemann, Stefan, Beissbarth, Tim, Schlomm, Thorsten, Sültmann, Holger, Korf, Ulrike
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908584/
https://www.ncbi.nlm.nih.gov/pubmed/20569466
http://dx.doi.org/10.1186/1477-5956-8-36
_version_ 1782184200709865472
author Brase, Jan C
Mannsperger, Heiko
Fröhlich, Holger
Gade, Stephan
Schmidt, Christian
Wiemann, Stefan
Beissbarth, Tim
Schlomm, Thorsten
Sültmann, Holger
Korf, Ulrike
author_facet Brase, Jan C
Mannsperger, Heiko
Fröhlich, Holger
Gade, Stephan
Schmidt, Christian
Wiemann, Stefan
Beissbarth, Tim
Schlomm, Thorsten
Sültmann, Holger
Korf, Ulrike
author_sort Brase, Jan C
collection PubMed
description BACKGROUND: Reverse phase protein arrays (RPPA) emerged as a useful experimental platform to analyze biological samples in a high-throughput format. Different signal detection methods have been described to generate a quantitative readout on RPPA including the use of fluorescently labeled antibodies. Increasing the sensitivity of RPPA approaches is important since many signaling proteins or posttranslational modifications are present at a low level. RESULTS: A new antibody-mediated signal amplification (AMSA) strategy relying on sequential incubation steps with fluorescently-labeled secondary antibodies reactive against each other is introduced here. The signal quantification is performed in the near-infrared range. The RPPA-based analysis of 14 endogenous proteins in seven different cell lines demonstrated a strong correlation (r = 0.89) between AMSA and standard NIR detection. Probing serial dilutions of human cancer cell lines with different primary antibodies demonstrated that the new amplification approach improved the limit of detection especially for low abundant target proteins. CONCLUSIONS: Antibody-mediated signal amplification is a convenient and cost-effective approach for the robust and specific quantification of low abundant proteins on RPPAs. Contrasting other amplification approaches it allows target protein detection over a large linear range.
format Text
id pubmed-2908584
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29085842010-07-23 Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification Brase, Jan C Mannsperger, Heiko Fröhlich, Holger Gade, Stephan Schmidt, Christian Wiemann, Stefan Beissbarth, Tim Schlomm, Thorsten Sültmann, Holger Korf, Ulrike Proteome Sci Methodology BACKGROUND: Reverse phase protein arrays (RPPA) emerged as a useful experimental platform to analyze biological samples in a high-throughput format. Different signal detection methods have been described to generate a quantitative readout on RPPA including the use of fluorescently labeled antibodies. Increasing the sensitivity of RPPA approaches is important since many signaling proteins or posttranslational modifications are present at a low level. RESULTS: A new antibody-mediated signal amplification (AMSA) strategy relying on sequential incubation steps with fluorescently-labeled secondary antibodies reactive against each other is introduced here. The signal quantification is performed in the near-infrared range. The RPPA-based analysis of 14 endogenous proteins in seven different cell lines demonstrated a strong correlation (r = 0.89) between AMSA and standard NIR detection. Probing serial dilutions of human cancer cell lines with different primary antibodies demonstrated that the new amplification approach improved the limit of detection especially for low abundant target proteins. CONCLUSIONS: Antibody-mediated signal amplification is a convenient and cost-effective approach for the robust and specific quantification of low abundant proteins on RPPAs. Contrasting other amplification approaches it allows target protein detection over a large linear range. BioMed Central 2010-06-22 /pmc/articles/PMC2908584/ /pubmed/20569466 http://dx.doi.org/10.1186/1477-5956-8-36 Text en Copyright ©2010 Brase et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Brase, Jan C
Mannsperger, Heiko
Fröhlich, Holger
Gade, Stephan
Schmidt, Christian
Wiemann, Stefan
Beissbarth, Tim
Schlomm, Thorsten
Sültmann, Holger
Korf, Ulrike
Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
title Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
title_full Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
title_fullStr Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
title_full_unstemmed Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
title_short Increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
title_sort increasing the sensitivity of reverse phase protein arrays by antibody-mediated signal amplification
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908584/
https://www.ncbi.nlm.nih.gov/pubmed/20569466
http://dx.doi.org/10.1186/1477-5956-8-36
work_keys_str_mv AT brasejanc increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT mannspergerheiko increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT frohlichholger increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT gadestephan increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT schmidtchristian increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT wiemannstefan increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT beissbarthtim increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT schlommthorsten increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT sultmannholger increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification
AT korfulrike increasingthesensitivityofreversephaseproteinarraysbyantibodymediatedsignalamplification